Page 147 - Read Online

Zhu et al. Function of Mcl-1 and its regulative relations with HCC

Tsai FJ, Li LY, Tsai CH, Hung MC. Down-regulation of myeloid cell Cell Biol 2005;25:3117-26.
leukemia-1 through inhibiting Erk/Pin 1 pathway by sorafenib facilitates 87. MacDonald SM, Rafnar T, Langdon J, Lichtenstein LM. Molecular
chemosensitization in breast cancer. Cancer Res 2008;68:6109-17. identification of an IgE-dependent histamine-releasing factor. Science
70. Wang B, Chen L, Ni Z, Dai X, Qin L, Wu Y, Li X, Xu L, Lian J, 1995;269:688-90.
He F. Hsp90 inhibitor 17-AAG sensitizes Bcl-2 inhibitor (-)-gossypol 88. Li F, Zhang D, Fujise K. Characterization of fortilin, a novel
by suppressing ERK-mediated protective autophagy and Mcl- antiapoptotic protein. J Biol Chem 2001;276:47542-9.
1 accumulation in hepatocellular carcinoma cells. Exp Cell Res 89. Gachet Y, Tournier S, Lee M, Lazaris-Karatzas A, Poulton T, Bommer
2014;328:379-87. UA. The growth-related, translationally controlled protein P23 has
71. Inoshita S, Takeda K, Hatai T, Terada Y, Sano M, Hata J, Umezawa A, properties of a tubulin binding protein and associates transiently with
Ichijo H. Phosphorylation and inactivation of myeloid cell leukemia 1 microtubules during the cell cycle. J Cell Sci 1999;112:1257-71.
by JNK in response to oxidative stress. J Biol Chem 2002;277:43730- 90. Chen YL, Yan MY, Chien SY, Kuo SJ, Chen DR, Cheng CY, Su
4. CC. Sann-Joong-Kuey-Jian-Tang inhibits hepatocellular carcinoma
72. Kodama Y, Taura K, Miura K, Schnabl B, Osawa Y, Brenner DA. Hep-G2 cell proliferation by increasing TNF-alpha, Caspase-8,
Antiapoptotic effect of c-Jun N-terminal Kinase-1 through Mcl-1 Caspase- 3 and Bax but by decreasing TCTP and Mcl-1 expression in
stabilization in TNF-induced hepatocyte apoptosis. Gastroenterology vitro. Mol Med Rep 2013;7:1487-93.
2009;136:1423-34. 91. Cheng CY, Lin YH, Su CC. Curcumin inhibits the proliferation of
73. Wang B, Ni Z, Dai X, Qin L, Li X, Xu L, Lian J, He F. The Bcl-2/xL human hepatocellular carcinoma J5 cells by inducing endoplasmic
inhibitor ABT-263 increases the stability of Mcl-1 mRNA and protein reticulum stress and mitochondrial dysfunction. Int J Mol Med
in hepatocellular carcinoma cells. Mol Cancer 2014;13:98. 2010;26:673-8.
74. Wang W, Wang YQ, Meng T, Yi JM, Huan XJ, Ma LP, Tong LJ, 92. Shapiro GI. Preclinical and clinical development of the cyclin-
Chen Y, Ding J, Shen JK, Miao ZH. MCL-1 degradation mediated dependent kinase inhibitor flavopiridol. Clin Cancer Res
by JNK activation via MEKK1/TAK1-MKK4 contributes to 2004;10:s4270-5.
anticancer activity of new tubulin inhibitor MT189. Mol Cancer Ther 93. Miyashita K, Shiraki K, Fuke H, Inoue T, Yamanaka Y, Yamaguchi
2014;13:1480-91. Y, Yamamoto N, Ito K, Sugimoto K, Nakano T. The cyclin-dependent
75. Maurer U, Charvet C, Wagman AS, Dejardin E, Green DR. kinase inhibitor flavopiridol sensitizes human hepatocellular
Glycogen synthase kinase-3 regulates mitochondrial outer membrane carcinoma cells to TRAIL-induced apoptosis. Int J Mol Med
permeabilization and apoptosis by destabilization of MCL-1. Mol Cell 2006;18:249-56.
2006;21:749-60. 94. Wittmann S, Bali P, Donapaty S, Nimmanapalli R, Guo F, Yamaguchi
76. Ding Q, He X, Hsu JM, Xia W, Chen CT, Li LY, Lee DF, Liu JC, H, Huang M, Jove R, Wang HG, Bhalla K. Flavopiridol down-
Zhong Q, Wang X, Hung MC. Degradation of Mcl-1 by beta-TrCP regulates antiapoptotic proteins and sensitizes human breast cancer
mediates glycogen synthase kinase 3-induced tumor suppression and cells to epothilone B-induced apoptosis. Cancer Res 2003;63:93-9.
chemosensitization. Mol Cell Biol 2007;27:4006-17. 95. Jung C, Motwani M, Kortmansky J, Sirotnak FM, She Y, Gonen M,
77. Opferman JT, Letai A, Beard C, Sorcinelli MD, Ong CC, Korsmeyer Haimovitz-Friedman A, Schwartz GK. The cyclin-dependent kinase
SJ. Development and maintenance of B and T lymphocytes requires inhibitor flavopiridol potentiates gamma-irradiation-induced apoptosis
antiapoptotic MCL-1. Nature 2003;426:671-6. in colon and gastric cancer cells. Clin Cancer Res 2003;9:6052-61.
78. Chen L, Willis SN, Wei A, Smith BJ, Fletcher JI, Hinds MG, 96. Schwickart M, Huang X, Lill JR, Liu J, Ferrando R, French DM,
Colman PM, Day CL, Adams JM, Huang DC. Differential targeting Maecker H, O’Rourke K, Bazan F, Eastham-Anderson J, Yue P,
of prosurvival Bcl-2 proteins by their BH3-only ligands allows Dornan D, Huang DC, Dixit VM. Deubiquitinase USP9X stabilizes
complementary apoptotic function. Mol Cell 2005;17:393-403. MCL1 and promotes tumour cell survival. Nature 2010;463:103-7.
79. Wang K, Gross A, Waksman G, Korsmeyer SJ. Mutagenesis of the 97. Liu H, Chen W, Liang C, Chen BW, Zhi X, Zhang S, Zheng X, Bai X,
BH3 domain of BAX identifies residues critical for dimerization and Liang T. WP1130 increases doxorubicin sensitivity in hepatocellular
killing. Mol Cell Biol 1998;18:6083-9. carcinoma cells through usp9x-dependent p53 degradation. Cancer
80. Cuconati A, Mukherjee C, Perez D, White E. DNA damage response Lett 2015;361:218-25.
and MCL-1 destruction initiate apoptosis in adenovirus-infected cells. 98. Zeng JY, Li SH, Wu XJ, Liu D, Wan X. Study on impact of ethanol
Genes Dev 2003;17:2922-32. extracts from Sedum sarmentosum in inhibiting STAT-3 signaling
81. Zhong Q, Gao W, Du F, Wang X. Mule/ARF-BP1, a BH3-only and inducing apoptosis of human hepatocellular carcinoma cell line
E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and HepG2. Zhongguo Zhong Yao Za Zhi 2014;39:3349-52. (in Chinese)
regulates apoptosis. Cell 2005;121:1085-95. 99. Yang CL, Jiang FQ, Xu F, Jiang GX. ADAM10 overexpression
82. Liao M, Zhao J, Wang T, Duan J, Zhang Y, Deng X. Role of bile confers resistance to doxorubicin-induced apoptosis in hepatocellular
salt in regulating Mcl-1 phosphorylation and chemoresistance in carcinoma. Tumour Biol 2012;33:1535-41.
hepatocellular carcinoma cells. Mol Cancer 2011;10:44. 100. Liu L, Cao Y, Chen C, Zhang X, McNabola A, Wilkie D, Wilhelm
83. Kobayashi S, Lee SH, Meng XW, Mott JL, Bronk SF, Werneburg S, Lynch M, Carter C. Sorafenib blocks the RAF/MEK/ERK
NW, Craig RW, Kaufmann SH, Gores GJ. Serine 64 phosphorylation pathway, inhibits tumor angiogenesis, and induces tumor cell
enhances the antiapoptotic function of Mcl-1. J Biol Chem apoptosis in hepatocellular carcinoma model PLC/PRF/5. Cancer Res
2007;282:18407-17. 2006;66:11851-8.
84. Cho SJ, Kim YJ, Surh YJ, Kim BM, Lee SK. Ibulocydine is a 101. Cragg MS, Harris C, Strasser A, Scott CL. Unleashing the power
novel prodrug Cdk inhibitor that effectively induces apoptosis in of inhibitors of oncogenic kinases through BH3 mimetics. Nat Rev
hepatocellular carcinoma cells. J Biol Chem 2011;286:19662-71. Cancer 2009;9:321-6.
85. Sun CK, Chua MS, He J, So SK. Suppression of glypican 3 inhibits 102. Khaw SL, Huang DC, Roberts AW. Overcoming blocks in apoptosis
growth of hepatocellular carcinoma cells through up-regulation of with BH3-mimetic therapy in haematological malignancies. Pathology
TGF-beta2. Neoplasia 2011;13:735-47. 2011;43:525-35.
86. Liu H, Peng HW, Cheng YS, Yuan HS, Yang-Yen HF. Stabilization 103. Zhang S, Li G, Ma X, Wang Y, Liu G, Feng L, Zhao Y, Zhang
and enhancement of the antiapoptotic activity of mcl-1 by TCTP. Mol G, Wu Y, Ye X, Qin B, Lu J. Norcantharidin enhances ABT-737-
Hepatoma Research ¦ Volume 3 ¦ July 06, 2017 139